305 related articles for article (PubMed ID: 23340844)
1. Genome-wide analysis of FOXO3 mediated transcription regulation through RNA polymerase II profiling.
Eijkelenboom A; Mokry M; de Wit E; Smits LM; Polderman PE; van Triest MH; van Boxtel R; Schulze A; de Laat W; Cuppen E; Burgering BM
Mol Syst Biol; 2013; 9():638. PubMed ID: 23340844
[TBL] [Abstract][Full Text] [Related]
2. FOXO3 selectively amplifies enhancer activity to establish target gene regulation.
Eijkelenboom A; Mokry M; Smits LM; Nieuwenhuis EE; Burgering BM
Cell Rep; 2013 Dec; 5(6):1664-78. PubMed ID: 24360957
[TBL] [Abstract][Full Text] [Related]
3. SMAD3 augments FoxO3-induced MuRF-1 promoter activity in a DNA-binding-dependent manner.
Bollinger LM; Witczak CA; Houmard JA; Brault JJ
Am J Physiol Cell Physiol; 2014 Aug; 307(3):C278-87. PubMed ID: 24920680
[TBL] [Abstract][Full Text] [Related]
4. FOXO3 is a glucocorticoid receptor target and regulates LKB1 and its own expression based on cellular AMP levels via a positive autoregulatory loop.
Lützner N; Kalbacher H; Krones-Herzig A; Rösl F
PLoS One; 2012; 7(7):e42166. PubMed ID: 22848740
[TBL] [Abstract][Full Text] [Related]
5. FOXO transcription factors control E2F1 transcriptional specificity and apoptotic function.
Shats I; Gatza ML; Liu B; Angus SP; You L; Nevins JR
Cancer Res; 2013 Oct; 73(19):6056-67. PubMed ID: 23966291
[TBL] [Abstract][Full Text] [Related]
6. FOXO3 modulates endothelial gene expression and function by classical and alternative mechanisms.
Czymai T; Viemann D; Sticht C; Molema G; Goebeler M; Schmidt M
J Biol Chem; 2010 Apr; 285(14):10163-78. PubMed ID: 20123982
[TBL] [Abstract][Full Text] [Related]
7. E2F transcription factor 1 regulates cellular and organismal senescence by inhibiting Forkhead box O transcription factors.
Xie Q; Peng S; Tao L; Ruan H; Yang Y; Li TM; Adams U; Meng S; Bi X; Dong MQ; Yuan Z
J Biol Chem; 2014 Dec; 289(49):34205-13. PubMed ID: 25344604
[TBL] [Abstract][Full Text] [Related]
8. Posttranslational modifications control FoxO3 activity during denervation.
Bertaggia E; Coletto L; Sandri M
Am J Physiol Cell Physiol; 2012 Feb; 302(3):C587-96. PubMed ID: 22094330
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA 195-5p Targets
Bai Y; Pan B; Zhan X; Silver H; Li J
Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34201585
[TBL] [Abstract][Full Text] [Related]
10. The transcription of FOXO genes is stimulated by FOXO3 and repressed by growth factors.
Essaghir A; Dif N; Marbehant CY; Coffer PJ; Demoulin JB
J Biol Chem; 2009 Apr; 284(16):10334-42. PubMed ID: 19244250
[TBL] [Abstract][Full Text] [Related]
11. LKB1 downregulation may be independent of promoter methylation or FOXO3 expression in head and neck cancer.
Ekizoglu S; Dalay N; Karaman E; Akdeniz D; Ozaydin A; Buyru N
Transl Res; 2013 Aug; 162(2):122-9. PubMed ID: 23810581
[TBL] [Abstract][Full Text] [Related]
12. Interaction of transcription factor FoxO3 with histone acetyltransferase complex subunit TRRAP modulates gene expression and apoptosis.
Fusi L; Paudel R; Meder K; Schlosser A; Schrama D; Goebeler M; Schmidt M
J Biol Chem; 2022 Mar; 298(3):101714. PubMed ID: 35151693
[TBL] [Abstract][Full Text] [Related]
13. Direct activation of forkhead box O3 by tumor suppressors p53 and p73 is disrupted during liver regeneration in mice.
Kurinna S; Stratton SA; Tsai WW; Akdemir KC; Gu W; Singh P; Goode T; Darlington GJ; Barton MC
Hepatology; 2010 Sep; 52(3):1023-32. PubMed ID: 20564353
[TBL] [Abstract][Full Text] [Related]
14. Methylation by Set9 modulates FoxO3 stability and transcriptional activity.
Calnan DR; Webb AE; White JL; Stowe TR; Goswami T; Shi X; Espejo A; Bedford MT; Gozani O; Gygi SP; Brunet A
Aging (Albany NY); 2012 Jul; 4(7):462-79. PubMed ID: 22820736
[TBL] [Abstract][Full Text] [Related]
15. FOXO3 shares common targets with ASCL1 genome-wide and inhibits ASCL1-dependent neurogenesis.
Webb AE; Pollina EA; Vierbuchen T; Urbán N; Ucar D; Leeman DS; Martynoga B; Sewak M; Rando TA; Guillemot F; Wernig M; Brunet A
Cell Rep; 2013 Aug; 4(3):477-91. PubMed ID: 23891001
[TBL] [Abstract][Full Text] [Related]
16. High resolution mapping of enhancer-promoter interactions.
Reeder C; Closser M; Poh HM; Sandhu K; Wichterle H; Gifford D
PLoS One; 2015; 10(5):e0122420. PubMed ID: 25970635
[TBL] [Abstract][Full Text] [Related]
17. Loss of Interdependent Binding by the FoxO1 and FoxA1/A2 Forkhead Transcription Factors Culminates in Perturbation of Active Chromatin Marks and Binding of Transcriptional Regulators at Insulin-sensitive Genes.
Yalley A; Schill D; Hatta M; Johnson N; Cirillo LA
J Biol Chem; 2016 Apr; 291(16):8848-61. PubMed ID: 26929406
[TBL] [Abstract][Full Text] [Related]
18. The energy sensor AMP-activated protein kinase directly regulates the mammalian FOXO3 transcription factor.
Greer EL; Oskoui PR; Banko MR; Maniar JM; Gygi MP; Gygi SP; Brunet A
J Biol Chem; 2007 Oct; 282(41):30107-19. PubMed ID: 17711846
[TBL] [Abstract][Full Text] [Related]
19. Evaluating Enhancer Function and Transcription.
Field A; Adelman K
Annu Rev Biochem; 2020 Jun; 89():213-234. PubMed ID: 32197056
[TBL] [Abstract][Full Text] [Related]
20. Survival factor NFIL3 restricts FOXO-induced gene expression in cancer.
Keniry M; Pires MM; Mense S; Lefebvre C; Gan B; Justiano K; Lau YK; Hopkins B; Hodakoski C; Koujak S; Toole J; Fenton F; Calahan A; Califano A; DePinho RA; Maurer M; Parsons R
Genes Dev; 2013 Apr; 27(8):916-27. PubMed ID: 23630076
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
